Golden
Verge Genomics

Verge Genomics

Verge Genomics is a company focused on the discovery and development of drugs for the treatment of neurodegenerative diseases with the use of machine learning and computational genomics.

No article has been written about this topic yet.
Paste a URL about this topic to auto-extract knowledge.
Visit our Writing Guide for help on how to write about a topic,
and check out an example of a well filled out topic page.

No article has been written about this topic yet.
Be the first one to add some text.

Loading AI-assisted edit mode...

Timeline

July 2018

Verge Genomics raises a $32,000,000 series A round from OS Fund, WuXi AppTec Corporate Venture fund, ALS Investment Fund, DFJ and Agent Capital.

Funding rounds

Funding round
Funding round amount (USD)
Funding type
Funding round date
Investment
1 Result
Page 1 of 1
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn

Alice Zhang

Founder

Andrew Jiang

Investor

Dave Morin

Investor

Henry McNamara

Investor

Jason Chen

Founder

Kevin Colleran

Investor

Kimberly Vogel

Investor

Lucia Huang

Employee

Marlo Miller

Employee

Shannon Stone

Employee

Further reading

Title
Author
Link
Type
Date
+ Add new row

Documentaries, videos and podcasts

Title
Date
Link
+ Add new row

Companies

Company
CEO
Location
Products/Services
+ Add new row